High Proportion of Subjective Component to the Disease Activity Score is Associated with Favorable Response to Abatacept in Rheumatoid Arthritis.
Jeong Seok LeeHarris AhmadSeung-Cheol ShimSang-Cheol BaeYeong Wook SongEun Young LeePublished in: The patient (2020)
Trial name, Korean Post-marketing Surveillance for Orencia®. Trial registration number, NCT01583244. Registered on April 20, 2012.